rdf:type |
|
lifeskim:mentions |
umls-concept:C0003364,
umls-concept:C0004147,
umls-concept:C0008976,
umls-concept:C0013072,
umls-concept:C0014025,
umls-concept:C0019243,
umls-concept:C0020261,
umls-concept:C0028127,
umls-concept:C0035168,
umls-concept:C0087111,
umls-concept:C1257890,
umls-concept:C1274040,
umls-concept:C1707455,
umls-concept:C2603343
|
pubmed:issue |
7101
|
pubmed:dateCreated |
1997-8-28
|
pubmed:abstractText |
To compare the effectiveness and tolerability of hydrochlorothiazide, atenolol, nitrendipine, and enalapril in patients with mild to moderate hypertension.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0959-8138
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
19
|
pubmed:volume |
315
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
154-9
|
pubmed:dateRevised |
2008-11-20
|
pubmed:meshHeading |
pubmed-meshheading:9251545-Adult,
pubmed-meshheading:9251545-Aged,
pubmed-meshheading:9251545-Antihypertensive Agents,
pubmed-meshheading:9251545-Atenolol,
pubmed-meshheading:9251545-Blood Pressure,
pubmed-meshheading:9251545-Double-Blind Method,
pubmed-meshheading:9251545-Enalapril,
pubmed-meshheading:9251545-Female,
pubmed-meshheading:9251545-Humans,
pubmed-meshheading:9251545-Hydrochlorothiazide,
pubmed-meshheading:9251545-Hypertension,
pubmed-meshheading:9251545-Male,
pubmed-meshheading:9251545-Middle Aged,
pubmed-meshheading:9251545-Nitrendipine,
pubmed-meshheading:9251545-Sex Factors,
pubmed-meshheading:9251545-Treatment Outcome
|
pubmed:year |
1997
|
pubmed:articleTitle |
Randomised, double blind, multicentre comparison of hydrochlorothiazide, atenolol, nitrendipine, and enalapril in antihypertensive treatment: results of the HANE study. HANE Trial Research Group.
|
pubmed:affiliation |
Zentrum für Innere Medizin, Universitätsklinikum Essen, Germany.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|